| 000 | 01776 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516055005.0 | ||
| 264 | 0 | _c20120413 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1573-2592 | ||
| 024 | 7 |
_a10.1007/s10875-011-9588-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorte, Michael | |
| 245 | 0 | 0 |
_aEfficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cDec 2011 |
||
| 300 |
_a952-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunoglobulins _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xblood |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aQuinti, Isabella | |
| 700 | 1 | _aSoresina, Annarosa | |
| 700 | 1 | _aFernández-Cruz, Eduardo | |
| 700 | 1 | _aRitchie, Bruce | |
| 700 | 1 | _aSchmidt, Dirk S | |
| 700 | 1 | _aMcCusker, Christine | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 31 _gno. 6 _gp. 952-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-011-9588-5 _zAvailable from publisher's website |
| 999 |
_c21170538 _d21170538 |
||